These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 3584513)
1. View from the Nation's Capital. Drug abuse policy: policy or politics? Appler WD J Clin Psychopharmacol; 1987 Apr; 7(2):104-5. PubMed ID: 3584513 [No Abstract] [Full Text] [Related]
2. View from the nation's capital. Romansky MA J Clin Psychopharmacol; 1985 Feb; 5(1):51-2. PubMed ID: 2982923 [No Abstract] [Full Text] [Related]
3. View from the Nation's Capital. Romansky MA J Clin Psychopharmacol; 1984 Jun; 4(3):161-2. PubMed ID: 6096408 [No Abstract] [Full Text] [Related]
4. View from the Nation's Capital. Romansky MA J Clin Psychopharmacol; 1984 Feb; 4(1):52-4. PubMed ID: 6096407 [No Abstract] [Full Text] [Related]
5. Political science, public policy, and drug use prevention. Pentz MA; Mares D; Schinke S; Rohrbach LA Subst Use Misuse; 2004; 39(10-12):1821-65. PubMed ID: 15587952 [TBL] [Abstract][Full Text] [Related]
7. [Policy in matters of drug abuse. Analysis of the report of the expert commission for the revision of the federal law on narcotics (February 1996)]. Martin J Rev Med Suisse Romande; 1996 Aug; 116(8):651-3. PubMed ID: 8848690 [No Abstract] [Full Text] [Related]
8. Setting goals for drug policy: harm reduction or use reduction? Caulkins JP; Reuter P Addiction; 1997 Sep; 92(9):1143-50. PubMed ID: 9374012 [TBL] [Abstract][Full Text] [Related]
9. View from the Nation's Capital. Romansky MA J Clin Psychopharmacol; 1984 Oct; 4(5):288-9. PubMed ID: 6096409 [No Abstract] [Full Text] [Related]
11. View from the Nation's Capital. Investigational new drug (IND) and new drug application (NDA). Romansky MA J Clin Psychopharmacol; 1983 Jun; 3(3):193-4. PubMed ID: 6680405 [No Abstract] [Full Text] [Related]
12. View from the Nation's Capital. New drug application (NDA) and investigational new drug (IND) regulations. Romansky MA J Clin Psychopharmacol; 1983 Dec; 3(6):380-3. PubMed ID: 6680409 [No Abstract] [Full Text] [Related]
14. Physician Leadership on National Drug Policy: advocacy for an effective drug policy. Lewis DC Med Health R I; 1999 Mar; 82(3):101-4. PubMed ID: 10193141 [TBL] [Abstract][Full Text] [Related]
15. National drug control policy and prescription drug abuse: facts and fallacies. Manchikanti L Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776 [TBL] [Abstract][Full Text] [Related]
16. Drug policy reform: societal and clinical perspectives. Newman RG Bull N Y Acad Med; 1995; 72(2):321-34. PubMed ID: 10101372 [No Abstract] [Full Text] [Related]
17. View from the Nation's Capital: the Orphan Drug Act--prospects and problems. Romansky MA J Clin Psychopharmacol; 1984 Aug; 4(4):230-2. PubMed ID: 6470200 [No Abstract] [Full Text] [Related]
18. View from the Nation's Capital. FDA moves forward (and backwards) on a number of simmering issues. Appler WD J Clin Psychopharmacol; 1988 Feb; 8(1):57-8. PubMed ID: 3351001 [No Abstract] [Full Text] [Related]
19. Dealing with the drug problem. Jonas S Prev Med; 1994 Jul; 23(4):539-44. PubMed ID: 7971885 [TBL] [Abstract][Full Text] [Related]
20. The 70-minute hour: health administration in the nation's capital. Pardes H Pharos Alpha Omega Alpha Honor Med Soc; 1981; 44(2):2-8. PubMed ID: 7243854 [No Abstract] [Full Text] [Related] [Next] [New Search]